
Vital Farms experienced a poor quarter with collapsing profit margins, leading management to lower its fiscal 2026 guidance. Despite these challenges, the company still holds stronger economics compared to commodity egg producers due to its premium brand and relatively stable gross margins. After a 25% drop in its stock price, Vital Farms appears reasonably valued, but ongoing uncertainty about its pricing power and margin recovery suggests investors should remain cautious.